1. Catholic Healthcare Partners’Closing the “GAP”for Heart Failure Don Casey MD, MPH, MBA, FACP* Chief Medical Officer and Principal Investigator Catholic Health Partners…

Slide 1 Slide 2 19 102 patients, 51 countries, 1139 centers Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. Rationale, design, and baseline characteristics of the…

Slide 1Valve Replacement in Infective Endocarditis PJA Slabbert Cardiology Slide 2 Patient history 34 year male from NC Admitted KHC : 23/3/10 to 8/4/10 for Infective Endocarditis…

Slide 1ACUTE DECOMPENSATED HEART FAILURE : 2010 HFSA GUIDELINES BART COX, M.D., FACC ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE DIRECTOR,…

Page 1 Dr François Diévart Clinique Villette Dunkerque Place des statines dans la prise en charge du patient à haut risque cardiovasculaire Page 2 Rosuvastatin in Older…

Folie 1 Results of the Longest and Largest Ever -Blockade Study in CHF Mortality Reduction beyond ß 1 -Blockade Pub.: Results: Poole-Wilson et al. Lancet 2003;362:7-13 Design:…

1. Resynchronization/defibrillation for Ambulatory Heart Failure Trial RAFT A Multicentre Randomized Double BlindedControlled TrialAnthony S.L. Tang MD, George A. Wells PhD,…

1. Warong Lapanun MD.Bhumibol Adulyadej Hospital6/2/2011 2. Mr PM: 54-y-o presenting at a non-PCI hospital• 12.00 Myalgia and fatigueEpigastric fullness for 2 hrs• 12.30…

1. Panel 1st Module : Dyspnoea 1st Scenario Presented By 1A Group Thanks to our Tutor : dr. Sri Vitayani, Sp. KK Medical Faculty Universitas Muslim Indonesia 2010 2. 1A Group…

1. TDM OF DRUGS USED IN CARDIOVASCULAR DISEASES SENTHIL RAJ V. PHARM. D. Vth YEAR 2. CARDIOVASCULAR DISEASES • Cardiovascular drugs are primarily used for the treatment…